Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Prostate Cancer
Study Highlights TargetScan Touch for Improved Prostate Cancer Detection
May 26th, 2009
A study published by Duke University in the April 2009 edition of Technology in Cancer Research and Treatment, confirms that TargetScan® stereotactic prostate biopsy technology prostate cancer detection more frequently than traditional biopsy methods. Recent studies confirm the medical community's need for more confidence in diagnosing and determining appropriate treatment for prostate cancer. "Our team feels this platform is a very promising technique, allowing us to repeat biopsies and giving us higher probabilities of locating cancer within the prostate," explains Thomas J. Polascik, M.D., associate professor of urologic surgery at Duke...
Source: Cancer Weekly (2009-05-26)
|
